Clinical Efficacy and Safety of Dupilumab for the Treatment of Moderate to Severe Atopic Dermatitis in Korea: A Real-World Data in a Single Medical Center

Jongwook KIM; Yeona KIM; Sang-Hyeon WON; Kyung-Nam BAE; Jungsoo LEE; Kihyuk SHIN; Hoonsoo KIM; Hyunchang KO; Moon-Bum KIM; Byungsoo KIM.
Korean Journal of Dermatology ; : 429-436, 2023.
Artículo en Inglés | WPRIM | ID: wpr-1002162

Documentos relacionados

  1. [Chronic rhinosinusitis with nasal polyps-extension of dupilumab treatment intervals].
  2. [Treatment of atopic dermatitis with dupilumab : A retrospective cohort analysis from dermatological practice].
  3. [Psoriasis in dupilumab-treated atopic dermatitis].
  4. [Ocular symptoms associated with dupilumab in atopic dermatitis].
  5. [Dupilumab has an additional benefit in treatment of chronic rhinosinusitis with nasal polyps].
  6. [Treatment of simultaneously occurring urticaria and atopic dermatitis with dupilumab].
  7. [Experience with dupilumab in the treatment of chronic rhinosinusitis with nasal polyps].
  8. [Dupilumab-Associated Healing of Alopecia Areata in an Atopic Dermatitis Patient].
  9. [Recommendations when switching therapy from immunosuppressive drugs to dupilumab in patients with atopic dermatitis].
  10. [Hair growth with dupilumab in alopecia areata universalis and atopic dermatitis].